<DOC>
	<DOCNO>NCT01083342</DOCNO>
	<brief_summary>The purpose study evaluate complete response ( CR ) rate HD-MTX induction chemotherapy follow alternative HD MTX-based HD Cytarabine-based combination consolidation chemotherapy</brief_summary>
	<brief_title>High-Dose ( HD ) Methotrexate ( MTX ) Induction Chemotherapy Followed Alternative HD MTX-based HD Cytarabine-based Combination Consolidation Chemotherapy Newly Diagnosed Primary CNS Lymphoma ; CISL 10-01 Study</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Inclusion criterion 1 . Histologically confirm Primary Central Nervous System ( CNS ) lymphoma 2 . Previously untreated . Patients treat steroid alone eligible . 3 . Performance status : ECOG 03 . 4 . Age ; 2070 5 . Adequate renal function : Estimated glomerular filtration rate ( GFR ) estimate creatinine clearance ( CrCl ) ≥ 50 mL/min 6 . Adequate liver function : Transaminase ( AST/ALT ) &lt; 3 X upper normal value &amp; Bilirubin &lt; 2 X upper normal value 7 . Adequate hematological function : hemoglobin ≥ 9 g/dL absolute neutrophil count ( ANC ) ≥ 1,500/μL platelet count ≥ 75,000/μL 8 . At least one cerebral mass lesion magnetic resonance imaging ( MRI ) without involvement beyond central nervous system ( CNS ) 9 . Life expectancy &gt; 6 month 10 . A negative serum urine pregnancy test prior treatment must available pre menopausal woman woman &lt; 1 year onset menopause . 11 . Informed consent Exclusion criterion 1 . Other subtypes NHL Primary Central Nervous System ( CNS ) lymphoma 2 . Systemic involvement Primary CNS lymphoma except leptomeningeal involvement 3 . Intraocular lymphoma 4 . HIV ( + ) 5 . Any malignancy within past 5 year except curatively treat nonmelanoma skin cancer situ carcinoma cervix uteri 6 . Pregnant lactate woman , woman childbearing potential employ adequate contraception 7 . Other serious illness medical condition Unstable cardiac disease despite treatment , myocardial infarction within 6 month prior study entry History significant neurological psychiatric disorder Active uncontrolled infection ( viral , bacterial fungal infection ) 8 . Patients HBV ( + ) eligible . However , primary prophylaxis use antiviral agent ( i.e . lamivudine ) recommend HBV carrier prevent HBV reactivation whole treatment period . 9 . Concomitant administration experimental drug investigation , concomitant chemotherapy , hormonal therapy , immunotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>primary CNS lymphoma</keyword>
	<keyword>MTX : Methotrexate , Leucovorin</keyword>
	<keyword>MVD : Methotrexate , Vincristine , Dexamethasone</keyword>
	<keyword>VIA : VP-16 ( Etoposide ) , Ifosfamide , Mesna , Cytarabine ( ara-C )</keyword>
	<keyword>Newly diagnose primary CNS lymphoma patient</keyword>
</DOC>